One-Hundred and Fifth Regular Session
TUESDAY, June 8, 2021
The Chief Clerk made the following entries under the above date.
_____________
Chief Clerk's Entries
Amendments Offered
hist135201Senate Amendment 1 to Senate Bill 194 offered by Senator Testin. hist135187Senate Substitute Amendment 1 to Senate Bill 204 offered by Senator Stroebel. hist135175Senate Substitute Amendment 2 to Senate Bill 254 offered by Senator Feyen. _____________
Introduction, First Reading, and Reference of Proposals
Read and referred:
Relating to: honoring the life and public service of Dr. Lori Weyers.
By Senators Petrowski, Felzkowski, Bewley and Bernier; cosponsored by Representatives Snyder, Spiros, Edming, L. Myers, Mursau, Callahan and Tauchen.
hist135136To the committee on Senate Organization. _____________
Petitions and Communications
hist135240Pursuant to Senate Rule 17 (5), Representative Dittrich added as a cosponsor of Senate Bill 172. hist135248Pursuant to Senate Rule 17 (5), Representative L. Myers added as a cosponsor of Senate Bill 242. hist135241Pursuant to Senate Rule 17 (5), Representative Dittrich added as a cosponsor of Senate Bill 246. hist135138Pursuant to Senate Rule 17 (5), Senator Kooyenga added as a coauthor of Senate Bill 291. hist135262Pursuant to Senate Rule 17 (5), Representative Edming added as a cosponsor of Senate Bill 336. hist135263Pursuant to Senate Rule 17 (5), Representative Edming added as a cosponsor of Senate Bill 342. hist135134Pursuant to Senate Rule 17 (5), Representative Hintz added as a cosponsor of Senate Bill 361. hist135242Pursuant to Senate Rule 17 (5), Senator Smith added as a coauthor of Senate Bill 370. hist135261Pursuant to Senate Rule 17 (5), Representative Edming added as a cosponsor of Senate Bill 383. hist135243Pursuant to Senate Rule 17 (5), Senator Johnson added as a coauthor of Senate Resolution 7. _____________
Referrals and Receipt of Committee Reports Concerning Proposed Administrative Rules
The committee on Health reported and recommended:
Relating to removing FDA approved cannabidiol from schedule V and excluding FDA approved cannabidiol from schedule I.
hist135171Referred to the joint committee for review of Administrative Rules, June 8, 2021. PATRICK TESTIN
Chairperson
